viropharma
ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) Venture into a Multi-Million Merger to Expand Portfolios
Read the full article: http://blog.qualitystocks.net/?p=11207
Biopharmaceutical companies ViroPharma Inc. (Nasdaq: VPHM) and Lev Pharmaceuticals Inc. (OTCBB: LEVP) today announced a definitive merger agreement potentially worth $617.5 million to further joint efforts for the treatment of inflammatory diseases.
No ticker information available.
- Login or register to post comments
- Read more
- Email this page
Related Articles
- ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) Venture into a Multi-Million Merger to Expand Portfolios
- Chembio Diagnostics, Inc. (CEMI.OB) Reports Strong Third Quarter Results
- Medical Connections Holdings, Inc. (MCTH.OB) Reports 58% Revenue Increase
- GenVec, Inc.’s (GNVC) TNFerade™ Gets FDA Fast Track Designation for Pancreatic Cancer Treatment
- China Pharma Holdings Inc. (CPHI.OB) Posts Positive Q3 Results Across the Board